These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 16104127

  • 1. Current medical management of gastroesophageal reflux disease.
    Locke GR.
    Thorac Surg Clin; 2005 Aug; 15(3):369-75. PubMed ID: 16104127
    [Abstract] [Full Text] [Related]

  • 2. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ, Peters JH.
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [Abstract] [Full Text] [Related]

  • 3. Evolving issues in the management of reflux disease?
    Yuan Y, Hunt RH.
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [Abstract] [Full Text] [Related]

  • 4. Therapy for gastroesophageal reflux disease: more is not necessarily better.
    Metz DC.
    Am J Gastroenterol; 2003 Sep; 98(9):1913-5. PubMed ID: 14499765
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA, Paoletti V, Leite L, Castell DO.
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [Abstract] [Full Text] [Related]

  • 6. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J, Koek G, Demedts I, Sifrim D, Janssens J.
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [Abstract] [Full Text] [Related]

  • 7. A BALANCING VIEW: Empiric PPI therapy remains the champ, but not by a knock out!
    DeVault K.
    Am J Gastroenterol; 2006 Jan; 101(1):10-1. PubMed ID: 16405527
    [No Abstract] [Full Text] [Related]

  • 8. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM, McIntyre L, Bernard L, Fendrick AM.
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [Abstract] [Full Text] [Related]

  • 9. PRO: Empiric treatment with PPIs is not appropriate without testing.
    Belafsky PC.
    Am J Gastroenterol; 2006 Jan; 101(1):6-8. PubMed ID: 16405525
    [No Abstract] [Full Text] [Related]

  • 10. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
    Noar MD, Lotfi-Emran S.
    Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
    [Abstract] [Full Text] [Related]

  • 11. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
    Milkes D, Gerson LB, Triadafilopoulos G.
    Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
    [Abstract] [Full Text] [Related]

  • 12. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jun; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 13. CON: Treatment with PPIs should not be preceded by pH monitoring in patients suspected of laryngeal reflux.
    Vaezi MF.
    Am J Gastroenterol; 2006 Jan; 101(1):8-10. PubMed ID: 16405526
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of esophageal function/pH in endoscopic therapy for gastroesophageal reflux disease.
    Johnson DA.
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):333-45. PubMed ID: 15722245
    [Abstract] [Full Text] [Related]

  • 15. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G.
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [Abstract] [Full Text] [Related]

  • 16. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 17. Use of intragastric pH monitoring in gastroesophageal reflux disease.
    Katz PO.
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):277-87. PubMed ID: 15722241
    [Abstract] [Full Text] [Related]

  • 18. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M.
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [Abstract] [Full Text] [Related]

  • 19. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M, Triadafilopoulos G.
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [Abstract] [Full Text] [Related]

  • 20. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF, Khandwala F, Abelson TI, Hicks DM, Richter JE, Milstein C, Vaezi MF.
    Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.